Accessibility Menu
Integer logo

Integer(NYSE) ITGR

Market Cap$4.12BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2000)+384%
5 Year+24%
1 Year+12%
1 Month+28%
$121.08
+20.04%
+20.22Today
After hours$121.64+$0.57 (+0.47%)
Integer last closing stock price
MetricPriceDate
Last closeUSD 121.212026-07-31
Integer stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+22.91%USD 98.622026-07-24
1 month+28.17%USD 94.572026-07-01
3 month+44.25%USD 84.032026-05-01
Year to date+54.55%USD 78.432025-12-31
1 year+11.7%USD 108.512025-07-31
3 year+30.85%USD 92.632023-08-01
5 year+23.82%USD 97.892021-07-30
Since inception+383.89%USD 20.842000-09-29

Integer Financials at a Glance

Market Cap

$4.12BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$1.85B

Net Income (TTM)

$141.80M

EPS (TTM)

$4.01

P/E Ratio

30.20

Dividend

$0.00

Beta (Volatility)

0.88 (Low)

Price

$121.08

Volume

2,610,268

Open

$100.87

Previous Close

$121.21

Daily Range

$99.52 - $123.50

52-Week Range

$62.00 - $123.50

Estimated Earnings Date

Aug 6, 2026

ITGR: Motley Fool Moneyball Superscore

66

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Integer

Integer makes parts for medical devices like pacemakers. It helps big medical companies build tools for surgery. These products help doctors treat heart and brain conditions.

What Does Integer Build?

  • Cardio and Vascular: Provides parts for heart and blood vessel surgeries; accounts for 60% of sales in early 2026.
  • Cardiac Rhythm Management: Supplies components for pacemakers and heart failure therapies; represents 38% of sales.
  • Neuromodulation: Produces technology for spinal cord stimulators that help manage chronic pain.
  • Non-Medical Power: Develops specialized battery systems for the energy and military sectors; roughly 2% of sales.

Scaling Through Strategic Purchases

  • Acquired Precision Coating LLC in January 2025 to add advanced surface coating technology to its portfolio.
  • Purchased VSi Parylene in February 2025 to expand offerings in complex medical device coatings.
  • Completed the acquisition of Biocoat Incorporated assets in late 2025 to secure new hydrophilic coating platforms.
  • Invested 12 million euro in a convertible debt instrument with a life sciences firm in 2026.

Standing Out in Medical Manufacturing

Integer serves as a contract development and manufacturing organization, or CDMO. This means it designs and builds complex medical components for other healthcare brands. The company maintains a global production footprint with facilities in the United States, Ireland, Mexico, and Costa Rica.

By the Numbers

  • Sales reached $439.6 million in the first quarter of 2026, up 0.5% from $437.4 million a year earlier.
  • Net income improved to $16.5 million in the first quarter of 2026 from a loss of $22.5 million.
  • Operating cash flow was $24.7 million in the first quarter of 2026, down 21% from $31.3 million.
  • Free cash flow reached $737,000 in the first quarter of 2026, down 87.8% from $6.1 million in 2025.

Bottom Line

Integer has evolved into a specialized partner for the world's largest medical device manufacturers. Its strategy focuses on adding high-value coating technologies and maintaining a global supply chain for essential healthcare tools.

AI Generated • May 24, 2026

Industry

Healthcare Equipment and Supplies

Employees

11,000

CEO

Payman Khales, EMBA

Headquarters

Plano, TX 75024, US

ITGR Financials

Key Financial Metrics (TTM)

Gross Margin

23.31%

Operating Margin

10.41%

Net Income Margin

7.67%

Return on Equity

8.23%

Return on Capital

6.65%

Return on Assets

4.16%

Earnings Yield

3.31%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.12BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

33.95M

Volume

2.61M

Avg. Volume

531.55K

Financials (TTM)

Gross Profit

$431.27M

Operating Income

$192.57M

EBITDA

$332.57M

Operating Cash Flow

$189.57M

Capital Expenditure

-$89.77M

Free Cash Flow

$99.80M

Cash & ST Invst.

$8.12M

Total Debt

$1.38B

Integer Performance Analysis

Integer annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 1,378,169,00012.8%
20232023-12-31USD 1,554,726,00012.8%
20242024-12-31USD 1,719,849,00010.6%
20252025-12-31USD 1,846,466,0007.4%
Integer sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-278.4%
Q32025-09-26-1.3%
Q42025-12-310.9%
Q12026-04-03-6.7%
Integer annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 1.96-30.0%
20232023-12-31USD 2.7238.9%
20242024-12-31USD 3.3924.5%
20252025-12-31USD 2.89-14.7%
Integer sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-27257.6%
Q32025-09-266.7%
Q42025-12-3124.3%
Q12026-04-03-65.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$439.58M

+0.8%

Gross Profit

$109.60M

+3.5%

Gross Margin

24.93%

N/A

Market Cap

$4.12BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$374.15K

N/A

Employees

11,000

N/A

Net Income

$16.51M

+173.3%

EBITDA

$65.10M

+110.7%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$8.12M

-74.4%

Total Debt

$1.38B

+2.0%

Accounts Receivable

$327.78M

-13.6%

Inventory

$284.48M

+9.4%

Long Term Debt

$1.37B

+2.0%

Short Term Debt

$8.11M

-7.0%

Return on Assets

4.16%

N/A

Return on Invested Capital

6.01%

N/A

Free Cash Flow

$737.00K

-87.8%

Operating Cash Flow

$24.70M

-21.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CONConcentra Group Holdings Parent, Inc.
$31.65+0.09%
HAEHaemonetics Corporation
$85.54+0.85%
LIVNLivaNova PLC
$80.14-1.12%
ADUSAddus HomeCare Corporation
$115.48-1.03%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$200.75+0.03%
AAPLApple
$308.91-0.07%
AMZNAmazon
$271.58+0.15%
INTCIntel
$90.20-0.01%

Questions About ITGR

What is the current price of Integer?

Integer is trading at $121.21 per share.

What is the 52-week range for Integer?

Over the past 52 weeks, Integer has traded between $62.00 and $123.50.

How much debt does Integer have?

As of the most recent reporting period, Integer reported total debt of $1.38B.

How much cash does Integer have on hand?

Integer reported $8.12M in cash and cash equivalents in its most recent financial results.

What is Integer’s dividend yield?

Integer does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.